Sanofi (United States)

Recent papers from Sanofi (United States)

1. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trialsThe Lancet Diabetes & Endocrinology · 2021
2. Clinical History and Burden of Gaucher Disease Type 3: A Cross‐Sectional Multinational StudyWiley · 2026
3. Non-mandatory clinical outcome assessments in health technology assessment reviews in England, France, and Germany: exploratory associations with benefit ratings, pricing, and salesJournal of Patient-Reported Outcomes · 2026
4. Artificial intelligence in veterinary diagnostic histopathology: Concepts, applications, and clinical implementationVeterinary Pathology · 2026
5. Rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, in patients with warm autoimmune haemolytic anaemia: a prospective, single-arm, multicentre, phase 2b safety and clinical activity study (LUMINA 2)The Lancet Haematology · 2026
6. Artificial Intelligence Across the Pharmaceutical Life Cycle: Implications for Industry‐Based Clinical PharmacistsJACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026
7. Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated XTEND-Kids Phase III Trial Patients with Haemophilia APatient · 2026
8. Embracing triplet nitrenes for C-to-N replacement of complex bicyclic (hetero)aryl azidesScience · 2026
9. Patient Perspectives in Haemophilia A: Unmet Needs of Individuals Receiving Factor and Non‐Factor TreatmentsHaemophilia · 2026
10. Eosinophilic gastritis: burden of disease, diagnostic challenges and unmet needsGut · 2026
11. Exploration and validation of large language models as tools for molecular optimizationCommunications Chemistry · 2026
12. Burden of Invasive Meningococcal Disease: Evolving Epidemiology and Implications for Prevention PolicyInfectious Diseases and Therapy · 2026
13. Patient-Reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-Body Injector vs Manual Injection: Results From the Phase 2 IZALCO Study in Relapsed/Refractory Multiple MyelomaClinical Lymphoma Myeloma & Leukemia · 2026
14. Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 TrialEuropean Journal of Preventive Cardiology · 2026
15. High-dose vs. standard-dose influenza vaccine in heart failure: the FLUNITY-HD trialEuropean Heart Journal · 2026
16. Dupilumab Improves Endoscopic Features in Adult and Adolescent Patients With Eosinophilic Esophagitis: Post Hoc Analysis of LIBERTY EoE TREET StudyClinical and Translational Gastroenterology · 2026
17. Growth Assessment in Children Under 12 Years With Moderate‐to‐Severe Atopic Dermatitis Included in the PEDISTAD Observational RegistryPediatric Dermatology · 2026
18. A consensus framework for digital twin development in lyophilizationAAPS Open · 2026
19. Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target EffectsHuman Gene Therapy · 2026
20. Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studiesThe Lancet Respiratory Medicine · 2026